This text is a result of machine translation.
Shuidi company has established a new pharmaceutical innovation division to further develop the pharmaceutical direction
Research
Technology, Healthcare, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Bai chongen: it is suggested to use the price mechanism to distribute electricity and distribute the carbon emission quota to end users
Yi Ming ang Ke delivers a statement to the main board of the Hong Kong stock exchange to develop a new generation of tumor immunotherapy
Dialysis Provider Dakang Medical Raised CNY 400 Million Yuan in Series E Round.
This financing round was led by Ganjiang Kai Investment, a state-owned investment platform in Ganjiang, Jiangxi Province, and was followed by Central Enterprises Poor Regions Industry Investment Fund Co., and Neovision Capital.
Yesterday 04:16 PM
Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China
And platinum medicine b7h4x4-1bb bispecific antibody were approved by FDA for new drug research
Fosun pharma and Amgen have reached cooperation to accelerate the commercialization of two innovative drugs in China
It is expected to achieve functional cure of chronic hepatitis B! GSK antisense therapy phase IIB positive clinical results
EqualOcean Series: China VC Investment List Q2 2022
Yesterday 05:36 PM